Target Name: DUXAP3
NCBI ID: G503632
Review Report on DUXAP3 Target / Biomarker Content of Review Report on DUXAP3 Target / Biomarker
DUXAP3
Other Name(s): double homeobox A pseudogene 3 | Double homeobox A pseudogene 3

Exploring DUXAP3: A Pseudogene with Potential as A Drug Target

Double homeobox A pseudogene (DUXAP3) is a gene that has been identified in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study, and a potential drug candidate for human therapeutic use. In this article, we will explore the science behind DUXAP3, its potential as a drug target, and current research in the field.

The Double Homeobox Family

The double homeobox family is a group of genes that encode for proteins involved in the development and maintenance of tissues, including nervous system and immune cells. The member genes include: double homeobox A gene (DUXAP3), double homeobox B gene (DUXAP4), anddouble homeobox C gene (DUXAP5). The expression products of these genes include: double homeobox A protein (DHA), double homeobox B protein (DBP), double homeobox C protein (DCP).

DUXAP3: Structure and Function

DUXAP3 is a pseudogene that encodes for a protein with a unique structure and function. It consists of 1,944 amino acids and has a molecular weight of 21 kDa. DUXAP3 is localized to the nuclear envelope and cytoplasm, and is predominantly expressed in the brain.

The protein encoded by DUXAP3 has multiple functions, including:

1. cell adhesion: DUXAP3 is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. The protein helps to maintain the integrity of cell-cell and cell-extracellular matrix interactions, which are critical for normal tissue development and maintenance.

2. neuroprotection: DUXAP3 has been shown to protect neurons from oxidative stress and inflammation. It maintains the integrity of nerve cell membranes by regulating intracellular signaling pathways, and protects neurons by inhibiting oxidative stress and the generation of intracellular free radicals.

3. Immune cell regulation: DUXAP3 has been shown to regulate the development and function of immune cells, including T cells and natural killer cells. It is involved in the differentiation and memory of immune cells, as well as the regulation of immune responses.

4. Other functions: DUXAP3 is also involved in cell biological processes such as cell cycle, cell division, and apoptosis.

DUXAP3 as a Drug Target

DUXAP3 has emerged as a promising drug target due to its unique structure and function. The high level of expression and its role in a variety of diseases, including diseases of the nervous system and immune system, make DUXAP3 a promising drug target point.

At present, research on DUXAP3 as a drug target mainly focuses on the following aspects:

1. Regulatory mechanism of DUXAP3: Researchers are exploring the regulatory mechanism of DUXAP3 in cells, including post-transcriptional regulation, RNA-binding proteins and protein phosphorylation.

2. The mechanism of action of DUXAP3: Researchers are exploring the mechanism of action of DUXAP3, including interaction with intracellular molecules, signal transmission, and regulation of cell biological processes.

3. Clinical applications of DUXAP3: Researchers are exploring the application of DUXAP3 in the treatment of neurological and immune system diseases, including tumors, neurodegenerative diseases and autoimmune diseases.

Conclusion

DUXAP3 is a gene with unique structure and function and has been proven to play an important role in a variety of diseases. Due to its high expression and its prospect as a drug target, DUXAP3 is a promising drug target that can further study its importance and mechanism of action in the fields of molecular biology and medicine, providing new ideas for the treatment of various diseases. .

Protein Name: Double Homeobox A Pseudogene 3

The "DUXAP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUXAP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2 | EAPP | Early growth response | EARS2 | EBAG9 | EBF1 | EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P | EBNA1BP2 | EBP | EBPL | ECD | ECE1 | ECE1-AS1 | ECE2 | ECEL1 | ECEL1P1 | ECEL1P2 | ECH1 | ECHDC1 | ECHDC2 | ECHDC3 | ECHS1 | ECI1 | ECI2 | ECI2-DT | ECM1 | ECM2 | ECPAS | ECRG4 | ECSCR | ECSIT | ECT2 | ECT2L | Ectonucleoside triphosphate diphosphohydrolase | EDA | EDA2R | EDAR